Conventional risk factors for thoracic aortic aneurysm including dissection (tAA) are thought to include age, arteriosclerosis, and hypertension. In addition, evidence suggests that genetic factors play a role in the development of this condition. the purpose of the present study was to identify genetic variants that confer susceptibility to tAA in hypertensive subjects.
Thoracic aortic aneurysm including dissection (TAA) is a serious condition that results from an atherosclerotic aorta and is a leading cause of mortality. 1 Recent studies on the genetic basis of familial TAA have focused on its relation to systemic connective tissue disorders such as Marfan syndrome 2 and Ehlers-Danlos syndrome. 3 Up to 19% of patients with nonsyndromic TAA referred for surgery have been found to have affected first-degree relatives, supporting the notion that genetic factors influence the development of TAA in individuals without such syndromes. 4 Risk factors for TAA are thought to include age, arteriosclerosis, hypertension, and inflammatory or autoimmune diseases that affect the aorta. 5 However, although evidence suggests that genetic factors also play a role in the development of TAA, the genes that confer susceptibility to this condition remain largely unknown.
We have now performed an association study for 142 polymorphisms of 119 candidate genes and TAA in 1,351 Japanese individuals. The purpose of the present study was to identify genetic variants that confer susceptibility to TAA in hypertensive individuals and thereby to contribute to the personalized prevention of this condition. 
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patients were defined as individuals who either had a systolic blood pressure (BP) of ≥140 mm Hg or diastolic BP of ≥90 mm Hg (or both) or had taken antihypertensive drugs. Aortic aneurysm was defined as a permanent localized dilation of the aorta with a ≥50% increase in diameter relative to the expected normal diameter of the artery or with a diameter of >5 cm 6 Aortic dissection was defined as separation of the aortic wall layers, with resulting true and false lumens, or as intramural hematoma. 7 The subjects with TAA comprised 88 unrelated Japanese individuals (64 men, 24 women), all of whom were admitted to the hospitals and were examined initially by chest X-ray and echocardiography followed by contrast medium-enhanced computed tomography. Four TAA patients were also examined by angiography. The 88 subjects with TAA included 37 patients with aortic aneurysm (18 thoracic and 19 thoracoabdominal aortic aneurysms) and 51 patients with aortic dissecting aneurysm (15 Stanford type A and 36 Stanford type B dissections). Individuals with Marfan syndrome, Ehlers-Danlos syndrome, traumatic aneurysm, aortic bicuspid, arteritis, pseudoaneurysm, mycotic aneurysm, connective tissue disorder, congenital malformations of the heart or vessels, a familial history of aortic disease, or renal or endocrinologic diseases that cause secondary hypertension were excluded from the study.
The 1,263 hypertensive individuals (735 men, 528 women) who visited outpatient clinics of the participating hospitals for an annual health checkup or for the management of hypertension and did not have a history of cardiovascular, cerebrovascular, or aortic disease served as controls. All control subjects were examined by chest X-ray, with 162 individuals also being examined by echocardiography and 119 individuals by computed tomography. The study protocol complied with the Declaration of Helsinki and was approved by the Committees on the Ethics of Human Research of Mie University Graduate School of Medicine and other participating facilities and institutes. Written informed consent was obtained from each participant.
Selection of polymorphisms.
With the use of public databases, including PubMed (National Center for Biotechnology Information) and Online Mendelian Inheritance in Man (National Center for Biotechnology Information), we selected 119 candidate genes that have been characterized and suggested to be associated with TAA. On the basis of published studies or by searching PubMed and single-nucleotide polymorphism (SNP) databases [dbSNP (National Center for Biotechnology Information) and Japanese SNP database], we further selected 142 polymorphisms of these genes-most located in the promoter region or exons-that might be expected to result in changes in the function or expression of the encoded protein (Supplementary Table S1 online). We selected polymorphisms with a minor allele frequency of >0.05 in the original source. Given that the minor allele frequency may differ among ethnic groups, we did not perform a power calculation before the study. Wild-type and variant alleles of the polymorphisms were determined from the original sources.
Genotyping of polymorphisms. Venous blood (7 ml) was collected into tubes containing 50 mmol/l EDTA (disodium salt), and genomic DNA was isolated with a kit (Genomix; Talent, Trieste, Italy). Genotypes of the 142 polymorphisms were determined at G&G Science (Fukushima, Japan) by a method that combines the PCR and sequence-specific oligonucleotide probes with analysis by suspension array technology (Luminex 100 flow cytometer; Luminex, Austin, TX). Primers, probes, and other conditions for genotyping of polymorphisms related to TAA by the χ 2 -test are shown in Supplementary Table S2 online. Detailed methodology for genotyping was described previously. 8 To confirm the accuracy of genotyping by suspension array technology in the present study, we selected DNA samples from 23 subjects and genotyped 95 polymorphisms by chip-based matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. Only 4 of the 2,185 genotypes determined by this approach differed from those identified by suspension array technology. We then determined these four discrepant genotypes by DNA sequencing with a fluorescence-based automated DNA sequencer (Applied Biosystems, Foster City, CA) after amplification and cloning of the polymorphic regions. All four genotypes determined by DNA sequencing were identical to those determined by suspension array technology, demonstrating the accuracy of the latter approach in the present study.
Statistical analysis. Quantitative data were compared between subjects with TAA and controls by the unpaired Student's t-test. Categorical data were compared by the χ 2 -test. Allele frequencies were estimated by the gene counting method, and the χ 2 -test was used to identify departure from Hardy-Weinberg equilibrium. In the initial screen, the genotype distribution of each autosomal polymorphism was compared between subjects with TAA and controls by the χ 2 -test (3 × 2); for polymorphisms on the X chromosome, allele frequencies were compared by the χ 2 -test (2 × 2). Polymorphisms with a P value of <0.05 in the χ 2 -test were further examined by multivariable logistic regression analysis with adjustment for covariates, with TAA as a dependent variable and independent variables including age, sex (0 = woman, 1 = man), body mass index (BMI), smoking status (0 = nonsmoker, 1 = smoker), metabolic variables (0 = no history of diabetes mellitus or hypercholesterolemia, 1 = positive history), and genotype of each polymorphism. Each genotype was assessed according to dominant, recessive, and additive genetic models, and the P value, odds ratio, and 95% confidence interval were calculated. The additive genetic models each comprised two groups: heterozygotes vs. wild-type homozygotes for the additive 1 model, and variant homozygotes vs. wild-type homozygotes for the additive 2 model. To examine gene-environment interaction, we performed similar multivariable logistic regression analysis in smokers and nonsmokers separately. Finally, we performed a stepwise forward selection procedure to examine the effects of genotypes as well as of other covariates on TAA. A P value of <0.05 was considered significant. Statistical significance was examined by two-sided tests, which were performed with JMP version 5.1 software (SAS Institute, Cary, NC).
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The baseline characteristics of the study subjects are shown in Table 1 . Age, the proportion of men, and the prevalence of smoking were greater, whereas the prevalence of hypercholesterolemia was lower, in subjects with TAA than in controls. Evaluation of genotype distributions or allele frequencies by the χ 2 -test revealed that eight polymorphisms were related to the prevalence of TAA ( Table 2 ). The genotype distributions of these eight polymorphisms were all in Hardy-Weinberg equilibrium in both controls and subjects with TAA.
Multivariate logistic regression analysis with adjustment for age, sex, BMI, and the prevalence of smoking, diabetes mellitus, and hypercholesterolemia revealed that the −110A→C polymorphism of the heat shock 70-kDa protein 8 gene (HSPA8; dominant, recessive, and additive 1 and 2 models), the C→T (Pro198Leu) polymorphism of the glutathione peroxidase 1 gene (GPX1; dominant model), the −6G→A polymorphism of the angiotensinogen gene (AGT; dominant and additive 1 and 2 models), the −850C→T polymorphism of the tumor necrosis factor gene (TNF; dominant and additive 1 models), and the 3949T→G (3′ untranslated region) polymorphism of the thrombospondin-2 gene (THBS2; recessive and additive 2 models) were significantly associated with the prevalence of TAA ( Table 3) . The variant G allele of THBS2 was a risk factor for TAA, whereas the variant C allele of HSPA8, T allele of GPX1, A allele of AGT, and T allele of TNF were protective against this condition. Although we also performed multivariable logistic regression analysis in smokers and nonsmokers separately to examine potential gene-environment interaction, a significant interaction between smoking and the polymorphism of HSPA8, GPX1, AGT, TNF, or THBS2 was not detected (data not shown).
Finally, we performed a stepwise forward selection procedure to examine the effects of genotypes for the polymorphisms identified by the χ 2 -test as well as age, sex, BMI, and the prevalence of smoking, diabetes mellitus, and hypercholesterolemia on TAA ( Degenerative and dissecting aneurysms of the thoracic aorta develop as a result of progressive weakening of the aortic wall. They are associated with characteristic histological features including medial degeneration, which involves degeneration and fragmentation of elastic fibers, as well as loss of smooth muscle cells and an accumulation of basophilic ground substances. 9 The pathophysiology of such aneurysms is thought to be homogeneous despite variability in histopathologic features. 5, 9, 10 Studies on the pathophysiologic mechanism of TAA have focused on elastin degradation, smooth muscle cell depletion, and increased expression and tissue localization of elastin-and collagen-degrading enzymes, in particular matrix metalloproteinases (MMPs). 11 The upregulation of MMP-2 and MMP-9 was found to contribute to the degeneration of elastic fibers and deterioration of aortic contraction and mechanical properties associated with the pathogenesis of TAA. 12 THBS2 is a multifunctional protein that plays an autocrine role in the control of smooth muscle cell growth. 13 The expression of THBS2 is increased in human hypertrophied hearts. 14 A role for THBS2 in organization of the extracellular matrix is also suggested by the observation that disruption of Thbs2 in mice results in a complex phenotype characterized by abnormalities of fibroblasts, connective tissue, and blood vessels that are reminiscent of those associated with Ehlers-Danlos syndrome type IV. 15 Furthermore, a twofold increase in MMP-2 activity was found to contribute to the adhesive defect observed in THBS2-null fibroblasts. 16 Loss of THBS2 may result in an increase in MMP-2 levels in the pericellular environment 14 because THBS2 is capable of binding both the pro and mature forms of MMP-2. 17 The G allele of the 3949T→G (3′ untranslated region) polymorphism of THBS2 was previously associated with a reduced risk of premature myocardial infarction, possibly as a result of an increase in MMP-2 activity. 18, 19 We have now shown that this polymorphism of THBS2 was associated with TAA, with the G allele representing a risk factor for this condition. Previous 9, 11, 12, 14, 16, 17 and our present observations suggest that the interaction between THBS2 and MMPs may play an important role in predisposition to TAA.
We observed that variant alleles of polymorphisms of AGT, TNF, GPX1, and HSPA8 were protective against the development of TAA, although the molecular mechanisms responsible for such protection remain to be elucidated. AGT encodes the precursor for angiotensin II, the effector peptide of the renin-angiotensin system. Angiotensin II induces aneurysm formation in hypercholesterolemic mice, and both MMP-2 and MMP-9 activities were found to be increased in aortic aneurysm tissue. 20 TNF can influence MMP gene expression through the activation of transcription factors that bind to specific response elements in the promoters of these genes. 9 The expression of TNF was found to be increased in aortic tissue affected by TAA. 21 GPX1 is a soluble selenoprotein that plays a pivotal role in protecting vessels against oxidative stress and atherogenesis. 22 It is possible that the T allele of the C→T (Pro198Leu) polymorphism of GPX1 is associated with increased antiatherosclerotic and antioxidative stress effects. 23 
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In the clinical setting, it is difficult for physicians to know who will develop TAA among the large number of hypertensive patients. Given the relatively low incidence of TAA in such patients, routine screening by chest computed tomography or ultrasonography is not cost-effective. Identification of genetic risk factors for TAA in hypertensive patients may thus facilitate risk stratification. The combination of genetic tests and routine examinations might provide a cost-effective means to manage this condition.
Although we have provided evidence for a genetic basis of predisposition to TAA, there are several limitations of our study: (i) Measurement of parameters of structural remodeling in the aorta was not performed in TAA patients or control subjects. (ii) We adopted the standard criterion of P < 0.05 for significant association in each step of the statistical analysis. Given the multiple comparisons of genotypes with TAA, it is not possible to exclude completely potential statistical errors such as type I error (false positives). (iii) It is also possible that one or more polymorphisms of THBS2, GPX1, AGT, TNF, or HSPA8 are in linkage disequilibrium with polymorphisms in the same gene or nearby genes that are actually responsible for the development of TAA. (iv) The functional relevance of the association of the identified polymorphisms with TAA remains to be determined. (v) Given the small sample size for subjects with TAA in the present study, the observed associations will require replication in large and independent subject panels.
In conclusion, our present results suggest that the G allele of the 3949T→G (3′ untranslated region) polymorphism of THBS2 is a risk factor for TAA, whereas the C allele of the −110A→C polymorphism of HSPA8, the T allele of the C→T (Pro198Leu) polymorphism of GPX1, the A allele of the −6G→A polymorphism of AGT, and the T allele of the −850C→T polymorphism of TNF are protective against this condition in Japanese hypertensive individuals. Determination of genotypes for these polymorphisms may prove informative for assessment of the genetic risk for TAA and may contribute to the personalized prevention of this condition. Given that our study is preliminary and hypothesis generating, validation of our findings will require additional studies with large and independent subject panels.
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